Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Adipose-Derived Cellular Stromal Vascular Fraction (AD-cSVF) Parenterally in Post-Concussion Injuries and Traumatic Brain Injuries (TBI)

NCT02959294 is registered in ClinicalTrials.gov with Robert W. Alexander, MD, FICS as lead sponsor.

NCT NCT02959294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02959294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Adipose-Derived Cellular Stromal Vascular Fraction (AD-cSVF) Parenterally in Post-Concussion Injuries and Traumatic Brain Injuries (TBI)
Lead sponsor
Robert W. Alexander, MD, FICS
Phase
Phase 1
Overall status
Withdrawn
Start date
November 30, 2018
Completion date
March 31, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

concussion, brain, concussion, intermediate, concussion, mild, concussion, severe, traumatic encephalopathies, chronic